Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Brine ‘impatient’ to expand ‘innovative’ pharmacy hepatitis service

The pharmacy minister has told MPs he is “impatient” to see a hepatitis C testing pilot in London pharmacies “scaled out”.

In a parliamentary debate last week (June 12), Mr Brine referred to his visit to Portmans Pharmacy in Pimlico in April – which C+D attended – where he heard how the pilot had entered its second three-month phase, following a successful rollout that saw half of injecting drug users testing positive for the virus.

The pilot ran across eight pharmacies – including Portmans – from November 2017 to February 2018, while the second phase began at the end of April.

In response to a question from doctor and Conservative MP Daniel Poulter on how the government will ensure antivirals are made available to patients with hepatitis C, Mr Brine said the “approach of Portmans Pharmacy and the London joint working group [overseeing the pilot] is innovative”.

“I pay great tribute to the work that the group has done,” he added. “It has rightly received a lot of coverage and a lot of plaudits.”

“I am anxious and impatient – as my officials know, I am impatient about everything – to see the peer-reviewed results of that work and where we can scale it out more.”

At time of going to press, Mr Brine’s office had not responded to C+D’s query about how the government would consider scaling up the pilot.

Would you like to offer a hepatitis C testing service in your pharmacy?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD005378

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel